Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18204
Country/Region: Kenya
Year: 2017
Main Partner: University of Nairobi
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $4,381,085 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $262,284
Testing: HIV Testing and Counseling (HVCT) $529,401
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $561,261
Treatment: Adult Treatment (HTXS) $2,823,406
Treatment: Pediatric Treatment (PDTX) $204,733
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 102
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 965
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 138
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 3,264
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 136
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 2,058
GEND_GBV Number of people receiving post-GBV care 2018 274
GEND_GBV Number of people receiving post-GBV care 2018 5,324
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 255,882
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 1,898
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 1
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 47
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 26
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: <15, Negative 2018 2,781
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 25,287
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 939
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 790
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 8,066
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 4,934
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 9,149
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 6,817
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 93,234
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 61,427
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 101
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 68
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 1,091
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 705
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 1,256
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 904
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 13,299
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 8,561
HTS_TST Sum of Test Result disaggregates 2018 4,982
HTS_TST_POS By Test Result: Positive 2018 4,982
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 88
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: <15, Positive 2018 67
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 558
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 15
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 14
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 170
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 82
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 171
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 122
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 1,714
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 1,067
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 17
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 9
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive 2018 20
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 237
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 149
PMTCT_ART Already on ART at beginning of current pregnancy 2018 911
PMTCT_ART New on ART 2018 490
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 1,401
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 47,751
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 1,401
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 369
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 808
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 25
PMTCT_EID Unknown, <= 2 months 2018 164
PMTCT_EID Unknown, 2 - 12 months 2018 35
PMTCT_STAT By Age (Numerator): 15-19 2018 5,171
PMTCT_STAT By Age (Numerator): 20-24 2018 13,675
PMTCT_STAT By Age (Numerator): 25-49 2018 28,809
PMTCT_STAT By Age (Numerator): Unknown Age 2018 96
PMTCT_STAT By Number of known positives: 15-19 2018 490
PMTCT_STAT By Number of known positives: 20-24 2018 1,340
PMTCT_STAT By Number of known positives: 25-49 2018 2,841
PMTCT_STAT By Number of known positives: Unknown Age 2018 8
PMTCT_STAT By Number of new negative: 15-19 2018 4,442
PMTCT_STAT By Number of new negative: 20-24 2018 11,666
PMTCT_STAT By Number of new negative: 25-49 2018 24,561
PMTCT_STAT By Number of new negative: Unknown Age 2018 81
PMTCT_STAT By Number of new positives: 15-19 2018 239
PMTCT_STAT By Number of new positives: 20-24 2018 669
PMTCT_STAT By Number of new positives: 25-49 2018 1,407
PMTCT_STAT By Number of new positives: Unknown Age 2018 7
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 47,751
PMTCT_STAT_den By Age (Denominator): <15-19 2018 5,188
PMTCT_STAT_den By Age (Denominator): 10-14 2018 24
PMTCT_STAT_den By Age (Denominator): 20-24 2018 13,770
PMTCT_STAT_den By Age (Denominator): 25-49 2018 28,673
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 96
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 26
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 168
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 36
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 217
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 447
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 447
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 26
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 168
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 36
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 217
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 86
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 693
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 126
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 981
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 1,888
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 1,961
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 88
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 723
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 132
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,017
TX_CURR Aggregated Age/Sex: <15 Female 2018 1,008
TX_CURR Aggregated Age/Sex: <15 Male 2018 703
TX_CURR Aggregated Age/Sex: 15+ Female 2018 15,499
TX_CURR Aggregated Age/Sex: 15+ Male 2018 10,329
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 27,539
TX_CURR Sum of Aggregated Age/Sex <15 2018 1,711
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 25,828
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 27,539
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 455
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 307
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 1,748
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,136
TX_NEW Breastfeeding status 2018 196
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 3,905
TX_NEW Pregnancy status 2018 37
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 3,646
TX_PVLS <15, Undocumented Test Indication, Female 2018 212
TX_PVLS <15, Undocumented Test Indication, Female 2018 233
TX_PVLS <15, Undocumented Test Indication, Male 2018 111
TX_PVLS <15, Undocumented Test Indication, Male 2018 111
TX_PVLS 15+, Undocumented Test Indication, Female 2018 454
TX_PVLS 15+, Undocumented Test Indication, Female 2018 502
TX_PVLS 15+, Undocumented Test Indication, Male 2018 337
TX_PVLS 15+, Undocumented Test Indication, Male 2018 387
TX_PVLS Breastfeeding, Undocumented Test Indication 2018 63
TX_PVLS Breastfeeding, Undocumented Test Indication 2018 64
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 26,167
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 23,396
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,605
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 648
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,913
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 320
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 7,622
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,353
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 5,824
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 996
TX_PVLS Numerator: Indication: Routine 2018 18,965
TX_PVLS Numerator: Indication: Targeted 2018 3,316
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 975
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 187
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 197
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 34
TX_PVLS Pregnant, Undocumented Test Indication 2018 10
TX_PVLS Pregnant, Undocumented Test Indication 2018 12
TX_PVLS Undocumented Test Indication 2018 1,115
TX_PVLS Undocumented Test Indication 2018 1,232
TX_PVLS Unknown Age, Routine, Female 2018 1
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 4,100
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 736
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2,183
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 382
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 8,319
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,593
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 6,417
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,201
TX_PVLS_den Denominator: Indication: Routine 2018 21,020
TX_PVLS_den Denominator: Indication: Targeted 2018 3,912
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 1,100
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 204
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 219
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 42
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 431
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 301
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,795
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,192
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 3,719
TX_RET Numerator by Status: Breastfeeding 2018 184
TX_RET Numerator by Status: Pregnant 2018 33
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 3,731
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 431
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 302
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,799
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,199
TX_RET_den Denominator by Status: Breastfeeding 2018 184
TX_RET_den Denominator by Status: Pregnant 2018 33
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 172
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 172
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 6
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 8
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 62
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 96
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 6
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 8
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 63
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 95
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 68
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 22
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 82
TX_TB_den Denominator: By Screen Result: Negative 2018 99
TX_TB_den Denominator: By Screen Result: Positive 2018 72
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 166
Cross Cutting Budget Categories and Known Amounts Total: $1,897,890
Gender: Gender Based Violence (GBV) $150,000
Post GBV Care
Implementation
Capacity building
GBV Prevention
Implementation
Capacity building
Gender: Gender Equality $150,000
Equity in HIV prevention, care, treatment and support
Implementation
Capacity building
Key Populations: Sex Workers $150,000
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Key Populations: MSM and TG $100,000
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Human Resources for Health $1,347,890